LON:AZN - AstraZeneca Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
GBX 6,129 +33.00 (+0.54 %)
(As of 02/22/2019 04:49 AM ET)
Previous CloseGBX 6,096
Today's RangeGBX 6,081 - GBX 6,138
52-Week RangeGBX 4,260 - GBX 5,520
Volume187,886 shs
Average Volume2.31 million shs
Market Capitalization£77.66 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

AstraZeneca (LON:AZN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
22 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months. Their average twelve-month price target is GBX 6,222.20The high price target for AZN is GBX 8,500 and the low price target for AZN is GBX 4,080. There are currently 2 sell ratings, 7 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldBuy
Consensus Rating Score: 2.502.452.432.57
Ratings Breakdown: 2 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: GBX 6,222.20GBX 6,243.45GBX 5,927.44GBX 5,665.33

AstraZeneca (LON:AZN) Consensus Price Target History

Price Target History for AstraZeneca (LON:AZN)

AstraZeneca (LON:AZN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/22/2019Bryan, Garnier & CoDowngradeNeutralView Rating Details
2/18/2019Deutsche BankReiterated RatingBuyGBX 6,900View Rating Details
2/15/2019Credit Suisse GroupSet Price TargetBuyGBX 6,350View Rating Details
2/14/2019JPMorgan Chase & Co.Set Price TargetBuyGBX 7,100View Rating Details
2/14/2019Jefferies Financial GroupSet Price TargetNeutralGBX 6,100View Rating Details
2/14/2019Goldman Sachs GroupSet Price TargetSellGBX 4,080View Rating Details
2/14/2019Liberum CapitalReiterated RatingHoldView Rating Details
2/14/2019Shore CapitalReiterated RatingBuyView Rating Details
2/5/2019BarclaysReiterated RatingOverweightView Rating Details
1/16/2019Societe GeneraleBoost Price TargetBuyGBX 8,400 ➝ GBX 8,500View Rating Details
12/14/2018Bank of AmericaSet Price TargetBuyGBX 7,200View Rating Details
12/14/2018Morgan StanleyBoost Price TargetEqual weightGBX 5,250 ➝ GBX 6,400View Rating Details
11/28/2018HSBCSet Price TargetSellGBX 4,860View Rating Details
11/22/2018Kepler Capital MarketsReiterated RatingBuyGBX 6,100View Rating Details
11/19/2018InvestecDowngradeHoldGBX 5,500 ➝ GBX 6,300View Rating Details
11/19/2018UBS GroupReiterated RatingNeutralGBX 5,900View Rating Details
11/9/2018CfraSet Price TargetNeutralGBX 6,200View Rating Details
9/25/2018CitigroupReiterated RatingBuyGBX 6,200View Rating Details
9/11/2018BNP ParibasSet Price TargetBuyGBX 6,500View Rating Details
6/8/2018Berenberg BankReiterated RatingBuyGBX 6,200View Rating Details
5/21/2018Sanford C. BernsteinUpgradeOutperformGBX 5,673 ➝ GBX 6,026View Rating Details
11/10/2017S&P GlobalSet Price TargetNeutralGBX 5,000View Rating Details
9/6/2017NatixisUpgradeNeutral ➝ BuyGBX 5,000 ➝ GBX 5,738View Rating Details
7/28/2017Beaufort SecuritiesDowngradeSellGBX 3,900View Rating Details
(Data available from 2/22/2017 forward)
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Featured Article: What is Depreciation?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel